Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)
The purpose of this study is to investigate additional cholesterol lowering effects in
 patients with coronary heart disease by giving an investigational drug with a patient's
 current approved cholesterol lowering medication.
The duration of treatment is 10 weeks.
Inclusion Criteria:

 -  Patients with elevated cholesterol and coronary heart disease

 Exclusion Criteria:

 -  Patients who have cholesterol levels within normal ranges as identified by the study